These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30726791)

  • 41. Associations between shift work and use of prescribed medications for the treatment of hypertension, diabetes, and dyslipidemia: a prospective cohort study.
    Tucker P; Härmä M; Ojajärvi A; Kivimäki M; Leineweber C; Oksanen T; Salo P; Vahtera J
    Scand J Work Environ Health; 2019 Sep; 45(5):465-474. PubMed ID: 30847495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. More Prevalent Prescription of Medicine for Hypertension and Metabolic Syndrome in Males from Couples Undergoing Intracytoplasmic Sperm Injection.
    Elenkov A; Al-Jebari Y; Giwercman A
    Sci Rep; 2018 Sep; 8(1):14521. PubMed ID: 30266963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum Lipid Goal Attainment in Chronic Kidney Disease (CKD) Patients under the Japan Atherosclerosis Society (JAS) 2012 Guidelines.
    Shimizu R; Torii H; Yasuda D; Hiraoka Y; Kitada N; Hashida T; Yoshimoto A; Kita T; Kume N
    J Atheroscler Thromb; 2015; 22(9):949-57. PubMed ID: 25843151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of co-morbid mental illness on the diagnosis and management of patients hospitalized for medical conditions in a general hospital.
    Briskman I; Bar G; Boaz M; Shargorodsky M
    Int J Psychiatry Med; 2012; 43(4):339-48. PubMed ID: 23094466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dyslipidemia and prevention of atherosclerotic cardiovascular disease in the elderly.
    Lucchi T
    Minerva Med; 2021 Dec; 112(6):804-816. PubMed ID: 33949178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lowering LDL-Cholesterol and CV Benefits: Is There a Limit to How Low LDL-C Needs to be for Optimal Health Benefits?
    Vani A; Underberg JA
    Clin Pharmacol Ther; 2018 Aug; 104(2):290-296. PubMed ID: 29882959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
    Cooke CE; Hammerash WJ
    Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Household income and LDL-C goal attainment in patients with diabetes and dyslipidemia in a Canadian dataset.
    Farahani P; Levine M
    Clin Invest Med; 2014 Feb; 37(1):E47-52. PubMed ID: 24502811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
    März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
    Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CONTROVERSIAL ISSUES IN THE TREATMENT OF DYSLIPIDEMIAS IN PATIENTS WITH DIABETES MELLITUS.
    Parhofer KG
    Rev Invest Clin; 2018; 70(5):237-243. PubMed ID: 30307445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in the treatment of dyslipidemia.
    Sabatine MS
    Cleve Clin J Med; 2016 Mar; 83(3):181-6. PubMed ID: 26974988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].
    Pérez A; González Blanco C; Hernández-Presa MÁ; Chaves J
    Endocrinol Nutr; 2011; 58(6):283-90. PubMed ID: 21641286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of low-dose aspirin in subjects with dyslipidemia.
    Lou G; Chen J; Xia Y
    Lipids Health Dis; 2016 Jun; 15():106. PubMed ID: 27313113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Second-line treatments for dyslipidemia in patients at risk of cardiovascular disease.
    Kondo Y; Hamai J; Nezu U; Shigematsu E; Kamiko K; Yamazaki S; Yoshii T; Takahashi M; Takano T; Kawasaki S; Yamada M; Yamakawa T; Terauchi Y
    Endocr J; 2014; 61(4):343-51. PubMed ID: 24452015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention.
    Sepúlveda C; Palomo I; Fuentes E
    Vascul Pharmacol; 2017 Apr; 91():10-17. PubMed ID: 28342822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan.
    Teramoto T; Uno K; Miyoshi I; Khan I; Gorcyca K; Sanchez RJ; Yoshida S; Mawatari K; Masaki T; Arai H; Yamashita S
    Atherosclerosis; 2016 Aug; 251():248-254. PubMed ID: 27419905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of vascular risk factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).
    Meschia JF; Voeks JH; Leimgruber PP; Mantese VA; Timaran CH; Chiu D; Demaerschalk BM; Howard VJ; Hughes SE; Longbottom M; Howard AG; Brott TG
    J Am Heart Assoc; 2014 Nov; 3(6):e001180. PubMed ID: 25428209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.